Compound of Glucosamine Hydrochloride and Chondroitin Sulfate in Treatment of Osteoarthritis: a Multicenter, Randomized and Double-Blind Trial

SHEN Yu-hui,ZHANG Wei-bin,ZHUANG Cheng-yu,JIANG Ru-shan,KOU Bo-long,SUN Ya-ning,LI Jian-min
DOI: https://doi.org/10.3969/j.issn.1007-7669.2006.11.011
2006-01-01
Abstract:AIM: To observe and confirm the efficacy and safety of the compound of glucosamine hydrochloride and chondroitin sulfate in the treatment of osteoarthritis. METHODS: Total 360 osteoarthritis patients were divided randomly into three groups in 5 centers, with 120 patients in every group. The two trial groups were taken individually the capsule and tablet of the compound of glucosamine hydrochloride and chondroitin sulfate respectively. The control group was taken the placebo. The trial groups contained glucosamine hydrochloride 150 mg and chondroitin sulfate 120 mg in either capsule or tablet dosage form, with administra tion of 3, po, tid and the placebo group with 3 tablets, po, tid. The whole course covered 3 mo. And then the clinical efficacy and safety together with adverse reactions were investigated and compared. RESULTS: The curative rates in the capsule and tablet trial groups were 92.5 % and 93.3 %, respectively (P 0.05), and that in control group was 20.8 %, showing statistical difference with the former two (P 0.05) . The adverse reaction rates of the capsule and tablet trial groups were 0.8 % and 3.3 %, with no statistical difference (P 0.05) . CONCLUSION: The compound of glucosamine hydrochloride and chondroitin sulfate capsule and tablet have the effectiveness and safety in the treatment of osteoarthritis.
What problem does this paper attempt to address?